Jens Bremerich

Magnetic Resonance Characterization of the Peri-Infarction Zone of Reperfused Myocardial Infarction With Necrosis-Specific and Extracellular Nonspecific Contrast Media

Background —Because ischemically injured myocardium is frequently composed of viable and nonviable portions, a method to discriminate the two is useful for clinical management. Methods and Results —Ischemically injured myocardium was characterized with extracellular nonspecific (Gd-DTPA) and necrosis-specific (mesoporphyrin) MR contrast media in rats. Relaxation rates (R1) were measured on day 1 and day 2 by inversion-recovery echoplanar imaging. Spin-echo imaging was used to define contrast-enhanced regions and regional wall thickening. Gadolinium concentration, area at risk, and infarct size were measured at postmortem examination. &Dgr;R1 ratio (&Dgr;R1myocardium/&Dgr;R1blood) after administration of Gd-DTPA was greater in ischemically injured myocardium (1.20±0.15) than in normal myocardium (0.47±0.05, P <0.05), which was attributed to differences in gadolinium concentration and water content. The Gd-DTPA–enhanced region on day 2 was larger (32.8±0.9%) than true infarction as demonstrated by triphenyltetrazolium chloride (TTC) (24.6±1.4%, P <0.001, r =0.21). Bland-Altman analysis revealed that the Gd-DTPA–enhanced region overestimated true infarct size by 7.8±5.9%. On the other hand, the mesoporphyrin-enhanced region (26.9±1.8%, P =NS, r =0.87) and true infarct size were identical. The difference in the areas demarcated by the 2 agents is the peri-infarction. Systolic and diastolic MR images revealed no wall thickening in the mesoporphyrin-enhanced region (0.3±3.3%) but reduced thickening in the Gd-DTPA–enhanced rim (8.5±5.5%, P <0.05). Conclusions —The Gd-DTPA–enhanced region encompasses both viable and nonviable portions of the ischemically injured myocardium. The Gd-DTPA–enhanced area overestimated infarct size, but the mesoporphyrin-enhanced area matched true infarct size. The salvageable peri-infarction zone can be characterized with double-contrast–enhanced and functional MR imaging; the mismatched area of enhancement between the 2 agents shows residual wall thickening.

Dynamic assessment of right ventricular volumes and function by real-time three-dimensional echocardiography: a comparison study with magnetic resonance imaging in 100 adult patients.

BACKGROUND The aim of this study was to validate a novel real-time three-dimensional echocardiographic (RT3DE) analysis tool for the determination of right ventricular volumes and function in unselected adult patients. METHODS A total of 100 consecutive adult patients with normal or pathologic right ventricles were enrolled in the study. A dynamic polyhedron model of the right ventricle was generated using dedicated RT3DE software. Volumes and ejection fractions were determined and compared with results obtained on magnetic resonance imaging (MRI) in 88 patients with adequate acquisitions. RESULTS End-diastolic, end-systolic, and stroke volumes were slightly lower on RT3DE imaging than on MRI (124.0 +/- 34.4 vs 134.2 +/- 39.2 mL, P < .001; 65.2 +/- 23.5 vs 69.7 +/- 25.5 mL, P = .02; and 58.8 +/- 18.4 vs 64.5 +/- 24.1 mL, P < .01, respectively), while no significant difference was observed for ejection fraction (47.8 +/- 8.5% vs 48.2 +/- 10.8%, P = .57). Correlation coefficients on Bland-Altman analysis were r = 0.84 (mean difference, 10.2 mL; 95% confidence interval [CI], -31.3 to 51.7 mL) for end-diastolic volume, r = 0.83 (mean difference, 4.5 mL; 95% CI, -23.8 to 32.9 mL) for end-systolic volume, r = 0.77 (mean difference, 5.7 mL; 95% CI, -24.6 to 36.0 mL) for stroke volume, and r = 0.72 (mean difference, 0.4%; 95% CI, -14.2% to 15.1%) for ejection fraction. CONCLUSION Right ventricular volumes and ejection fractions as assessed using RT3DE imaging compare well with MRI measurements. RT3DE imaging may become a time-saving and cost-saving alternative to MRI for the quantitative assessment of right ventricular size and function.

Coronary artery imaging with contrast-enhanced MDCT : Extracardiac findings

OBJECTIVE The purpose of our study was to evaluate the incidence of extracardiac findings on contrast-enhanced MDCT of the coronary arteries and to assess the effect of different field-of-view settings. SUBJECTS AND METHODS Patients with suspected coronary artery disease (n = 166) were examined with contrast-enhanced MDCT (16 x 0.75 mm focused on the heart) during injection of contrast material (80 mL injected at a rate of 4 mL/sec) followed by saline (20 mL injected at 4 mL/sec). Retrospectively gated images were reconstructed at a 1-mm slice thickness and a 0.5-mm increment with isotropic voxels of 1 mm3. Images were reviewed for extracardiac findings, which were then classified as none, minor, or major with respect to their impact on patient management and treatment. In a different group of patients (n = 20), chest scans (16 x 1.5 mm) were used for measuring volumes of displayed body structures on wholechest scans, coronary artery MDCT images, and coronary artery MDCT images reconstructed with the maximum field of view. RESULTS Extracardiac findings were detected in 41 patients (24.7%). Findings were classified as minor (19.9%) or major (4.8%). Among the major findings, which had an immediate impact on patient management and treatment, were bronchial carcinoma and pulmonary emboli. Volume analysis revealed that 35.5% of the total chest volume was displayed on dedicated coronary artery MDCT focused on the heart, whereas 70.3% of the chest was visible when coronary artery MDCT raw data were reconstructed with the maximal field of view (p < 0.001). CONCLUSION Coronary artery MDCT can reveal important findings and disease in extracardiac structures. Thus, the entire examination should be reconstructed with the maximum field of view and should be reviewed by a qualified radiologist.

Microvascular injury in reperfused infarcted myocardium: noninvasive assessment with contrast-enhanced echoplanar magnetic resonance imaging

OBJECTIVES The purpose of this study was to measure the accumulation of labeled albumin and to visualize its distribution pattern in reperfused infarcted myocardium as a function of time between onset of reperfusion and administration of the tracer. BACKGROUND Myocardial microvascular injury leads to leakage of albumin from the intravascular space. Quantitative measurements of GdDTPA-albumin with inversion recovery echoplanar imaging (IR-EPI) may allow noninvasive monitoring of microvascular injury. METHODS After 1 h of coronary artery occlusion, 56 rats were injected with GdDTPA-albumin or 123I-GdDTPA-albumin either immediately before reperfusion or 1/2, 1 or 24 h after reperfusion. GdDTPA-albumin in blood, normal myocardium and reperfused infarction was dynamically measured with IR-EPI during 1 h postinjection (PI). Autoradiograms were obtained at 15 min PI. Accumulation of labeled albumin in myocardium was expressed as the ratio of myocardial to blood content. RESULTS In normal myocardium, the ratio of changes of relaxation rate-ratio (deltaR1-ratio) was 0.12+/-0.01 and did not change over 1 h. In reperfused infarction, however, the deltaR1-ratio increased after administration. Animals given GdDTPA-albumin before reperfusion exhibited fastest accumulation (deltaR1-ratio 15 min PI: 0.56+/-0.03) and essentially homogeneous distribution. The accumulation was slower when administered at 1/2, 1 and 24 h after reperfusion (deltaR1-ratios 15 min PI: 0.39+/-0.03; 0.31+/-0.04; 0.16+/-0.01; p < 0.001 compared to administration before reperfusion). Moreover, the tracer accumulated predominantly in the periphery of the injury zone. CONCLUSIONS Amount and distribution pattern of labeled albumin in reperfused infarction are modulated by duration of reperfusion. The accumulation of GdDTPA-albumin can be quantified by IR-EPI. Thus, IR-EPI may be useful to noninvasively monitor myocardial microvascular injury in reperfused infarction.

Cerebral Venous Thrombosis: Diagnostic Accuracy of Combined, Dynamic and Static, Contrast-Enhanced 4D MR Venography

BACKGROUND AND PURPOSE: MR including MRV is an established method to diagnose CVT. However, it remains unsettled which MR imaging modalities offer the highest diagnostic accuracy. We evaluated the accuracy of a combined, dynamic (1.5 seconds per dataset) and static (voxel size, 1.1 × 0.9 × 1.5 mm), contrast-enhanced MRV method (combo-4D MRV) relative to other established MR/MRV modalities. MATERIALS AND METHODS: A total of 39 patients with CVT (n = 20) and control subjects (n = 19) underwent combo-4D MRV, 2D TOF MRV, GRE imaging, and T2W imaging. For these modalities, diagnostic accuracy (ROCs) for CVT affecting 53 out of 234 predefined venous segments was determined. Sensitivity and specificity were separately calculated for different stages of CVT (acute/subacute/chronic). RESULTS: Combo-4D MRV showed the highest accuracy (AUC, 0.99 [95% CI, 0.97–1.0]; sensitivity, 97% [84%–100%]) for thrombosed dural sinuses. For all thrombosed segments including cortical veins, its sensitivity was best (76% [64%–84%]; AUC, 0.92 [0.88–0.96]), followed by TOF MRV (72% [59%–81%]; AUC, 0.93 [0.88–0.97]). Even for chronic CVT, it showed a relatively high sensitivity of 67% (30%–90%). For thrombosed cortical veins alone, GRE images achieved the highest sensitivity (66% [46%–81%]; AUC, 0.88 [0.78–0.97]). Specificities of all modalities ranged from 96% to 99%. CONCLUSIONS: Combo-4D MRV showed an excellent accuracy for the diagnosis of dural sinus thrombosis. The analysis of dynamic patterns of contrast enhancement in dural sinuses appeared useful to identify chronic thrombosis. To diagnose thrombosed cortical veins, GRE images should primarily be analyzed.

Assessment of myocardial function and perfusion in a canine model of non-occlusive coronary artery stenosis using fast magnetic resonance imaging.

Magnetic resonance (MR) functional and perfusion imaging were employed in a canine model of coronary artery stenosis (n = 6) for the quantification of functional and perfusion deficits before and after dipyridamole administration. Left anterior descending and circumflex (LCX) coronary blood flow were measured continuously after placing Doppler flowmeters. Inversion recovery gradient echo images during the transit of MR contrast medium gadolinium‐benzyloxypropionictetraacetate dimeglumine (Gd‐BOPTA/Dimeg) and fast breath‐hold cine MR images were acquired at baseline, during LCX stenosis in basal state, and during LCX stenosis with vasodilation (dipyridamole 0.5 mg/kg). The extent of the functional defect and perfusion defect was expressed as percent of left ventricle (LV) circumference. During stenosis (LCX flow: 62.6 ± 5.6% of baseline) the extent of the functional defect was slightly larger than the perfusion defect (11.0 ± 1.8% versus 6.3 ± 1.7% of LV circumference, respectively; P < 0.01). During vasodilation the extent of the functional defect was considerably smaller than the perfusion defect (25.3 ± 2.5% versus 35.3 ± 3.5%; P < 0.01). Thus, the sizes of ischemic regions displayed by MR perfusion defect and functional defect differ from each other. J. Magn. Reson. Imaging 1999; 9:101–110. J. Magn. Reson. Imaging 1999;9:101–110

Functional assessment of the left atrium by real-time three-dimensional echocardiography using a novel dedicated analysis tool: initial validation studies in comparison with computed tomography

AIMS A novel real-time three-dimensional echocardiography (RT3DE) analysis tool specifically designed for evaluation of the left atrium enables comprehensive evaluation of left atrial (LA) size, global, and regional function using a dynamic 16-segment model. The aim of this study was the initial validation of this method using computed tomography (CT) as the method of reference. METHODS AND RESULTS The study population consisted of 34 prospectively enrolled patients with clinical indication for pulmonary vein isolation. A dynamic polyhedron model of the left atrium was generated using RT3DE. LA maximum and minimum volumes (LA(max)/LA(min)) and emptying fraction (LAEF) were determined and compared with the results obtained by CT. High correlations between RT3DE and CT were found for LA(max) (r = 0.92, P < 0.001), LA(min) (r = 0.95, P < 0.001), and LAEF (r = 0.82, P < 0.001). LA(max) and LA(min) were lower by RT3DE than by CT (95.0 ± 44.7 vs. 119.8 ± 50.5 mL, P < 0.001 and 58.1 ± 41.3 vs. 83.3 ± 52.6 mL, P < 0.001, respectively), whereas LAEF was measured higher by RT3DE (42.8 ± 15.2 vs. 34.2 ± 15.4%, P < 0.001, respectively). RT3DE measurements closely correlated in terms of intra-observer (intra-class correlation r = 0.99, r = 0.99, r = 0.96, respectively) and inter-observer variability (r = 0.97, r = 0.98, r = 0.88, respectively). CONCLUSIONS LA volumes and EF as assessed by RT3DE correlate highly with CT measurements, albeit there is some bias between the imaging modalities. Most importantly, RT3DE measurements using the novel dedicated LA analysis tool are robust in terms of observer variability and thus suitable for follow-up analyses.

Arrhythmogenic right ventricular cardiomyopathy: diagnostic and prognostic value of the cardiac MRI in relation to arrhythmia-free survival

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a potentially fatal disease, which is often difficult to diagnose. As a non-invasive test cardiac magnetic resonance imaging (CMR) has become an important tool in establishing the diagnosis. The aim of this study was to evaluate the diagnostic and prognostic value of CMR in patients with suspected ARVC and to assess the long-term outcome of patients with CMR-diagnosed ARVC. Thirty-six patients with suspected ARVC (26 male, 10 female, median age 41 years) underwent non-invasive and invasive clinical tests as gold standard for ARVC diagnosis. ARVC was clinically diagnosed in 19 patients and excluded in 17 patients. Both groups underwent CMR, and diagnosis was confirmed by CMR in 16/18 patients with clinically diagnosed ARVC (sensitivity 89%), and correctly excluded in 14/17 of patients with clinically excluded ARVC (specificity 82%). This result indicates a positive predictive value of the CMR of 84%, and a negative predictive value of 88%, respectively (p < 0.0001). Using a scoring system, multiple CMR parameters were compared in the two groups in regard of the clinical diagnosis. By univariate analysis, right ventricular fatty tissue infiltration (p = 0.0003) was predictive for diagnosis. Compared by outcome, 37% of patients with clinically and by CMR-diagnosed ARVC had an arrhythmic event during a mean follow-up of 16 ± 11 months. These data suggest that CMR is a highly sensitive and specific method to diagnose or exclude ARVC, and thus, has an important prognostic impact on predicting arrhythmia free survival.

Head-to-Head Comparison of Two-Dimensional and Three-Dimensional Echocardiographic Methods for Left Atrial Chamber Quantification with Magnetic Resonance Imaging

BACKGROUND Limited data are available on the accuracy of quantification methods for left atrial (LA) volumes using two-dimensional (2D) and particularly real-time three-dimensional echocardiographic (RT3DE) methods in comparison with a reference standard. The aim of this study was to perform a head-to-head comparison between 2D and RT3DE methods with magnetic resonance imaging (MRI) as the reference standard. METHODS LA volumes derived from 2D echocardiographic methods (i.e., biplane modified Simpsons, biplane area-length, and prolate ellipse methods) and from RT3DE methods (i.e., 4D LA Analysis and QLAB) in 60 consecutive patients were compared with MRI measurements. Offline analysis time was recorded. RESULTS The biplane modified Simpsons and area-length methods showed good intraclass correlations with MRI for maximum (r = 0.70 and r = 0.69, P < .001) and minimum (r = 0.83 and r = 0.82, P < .001) volumes. Although RT3DE methods led to moderate increases in correlations for maximum (r = 0.94 and 0.70, P < .001) and minimum (r = 0.95 and r = 0.90, P < .001) volumes and narrower Bland-Altman limits of agreement than 2D echocardiographic methods, offline analysis time was higher for RT3DE (155-161 vs 103-144 sec). Compared with MRI, maximum and minimum LA volumes were underestimated by -4.7% and -8.9%, respectively, using 4D LA Analysis, by -15.7% and -14.9% using QLAB, by -12.3% and -4.4% using the biplane Simpsons method, by -13.7% and -6.8% using the area-length method, and by -48.2% and -50.5% using the prolate ellipse method. CONCLUSIONS The biplane Simpsons and area-length methods offer reasonable accuracy for LA chamber quantification across a broad range of volumes, while RT3DE methods lead to a moderate improvement in accuracy at the cost of more elaborate offline analysis.

Three-dimensional MR imaging of pulmonary vessels and parenchyma with NC100150 injection (Clariscan).

The influence of increasing doses of NC100150 Injection (Clariscan™) and echo times on visualization of pulmonary vessels and parenchyma was evaluated. The effects of 0.5, 1, 2, 4, and 8 mg Fe/kg NC100150 Injection and echo times (TE) of 1.1, 1.8, 2.2, and 4.3 msec were determined in six dogs using breath‐hold three‐dimensional (3D) spoiled gradient‐echo magnetic resonance (MR) sequence. At 2 mg Fe/kg and TE of 1.1 msec, the signal‐to‐noise ratio of the central pulmonary arteries and parenchyma was significantly increased (5.3 ± 2.2 to 50.3 ± 2.4) and (2.2 ± 0.9 to 6.4 ± 1.1), respectively. Using the TE of 1.1 msec, signal intensity in the main arteries continued to increase with increasing dose. Moreover, the enhancement of pulmonary parenchyma and microvasculature had a positive dose response. 3D MR imaging with ultrashort echo time and 2 mg Fe/kg NC100150 Injection produces angiograms with strong vascular contrast and allows qualitative assessment of pulmonary parenchyma and microvasculature. J. Magn. Reson. Imaging 2000;11:622–628.